Protective effect of tumor necrosis factor α antibody on experimental necrotizing enterocolitis in the rat
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 40 (9) , 1440-1445
- https://doi.org/10.1016/j.jpedsurg.2005.05.043
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialPublished by Elsevier ,2002
- Does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?Alimentary Pharmacology & Therapeutics, 2001
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic EnvironmentAnnual Review of Immunology, 1999
- The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitisJournal of Pediatric Surgery, 1997
- Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitisThe Journal of Pediatrics, 1994
- Necrotizing Enterocolitis: A Review of Pathogenetic Mechanisms and Implications for PreventionPediatric Pathology, 1993
- Necrotizing enterocolitis: Role of platelet activating factor, endotoxin, and tumor necrosis factorThe Journal of Pediatrics, 1990
- The role of intraluminal tension and pH in the development of necrotizing enterocolitis: An animal modelJournal of Pediatric Surgery, 1987
- An experimental study of acute neonatal enterocolitis—the importance of breast milkJournal of Pediatric Surgery, 1974